Postoperative Efficacy Analysis of Patients with Facial Nerve Palsy Associated with Cholesteatoma Otitis Media: Our Experience with 32 Patients
J.-J. Wang,Yi Feng,H. Wang,Ya‐Fen Wu,Haibo Shi,Z.-N. Chen,Shankai Yin
DOI: https://doi.org/10.1111/coa.13035
IF: 2.729
2017-01-01
Clinical Otolaryngology
Abstract:Cholesteatoma, keratinizing stratified squamous epithelium found ectopically within the middle ear, is not an actual tumour. Gradual destruction of the bone is caused by a variety of mechanisms including enzymes, bone erosion, compression caused by oedema, and direct inflammation and infection of the nerve.1 Facial paralysis is a rare but recognised complication of cholesteatoma. In cases of cholesteatoma associated with facial paralysis, decompression with complete disease eradication is the main therapy. The study protocol was approved by the Institutional Review Board of the Affiliated Sixth People's Hospital of Shanghai Jiao Tong University. Thirty-two patients diagnosed with facial paralysis associated with cholesteatoma from January 2014 to April 2016 at the Department of ENT Head and Neck Surgery, the Affiliated Sixth People's Hospital, were included in this study. All patients underwent modified mastoidectomy and facial nerve decompression surgery. Among the 22 (68.8%) males and 10 (31.2%) females, 18 (56.2%) participants had lesions on the left side and 14 (43.8%) had them on the right (see Table 1). The facial nerve function was evaluated 1 year after the operation according to the House-Brackmann grading system: Grades I and II indicate a favourable prognosis, Grade III indicates an ordinary prognosis and Grades IV, V and VI signify a poor prognosis. Near-complete decompression ranged from the geniculate ganglion to the stylomastoid foramen. Partial decompression was performed when the extent of the cholesteatoma scope was limited and the degree of facial paralysis was mild, with ~3 mm on both ends of the facial nerve exposed after opening of the facial nerve tube. The data were analysed using spss software (ver. 20.0; IBM Corp., Armonk, NY, USA). A P value < .05 was considered to indicate statistical significance. The 32 patients had different levels of facial nerve canal damage caused by persistent damage of the nerve from cholesteatoma, inflammatory stimulation and ischaemic oedema. In 18 (56.25%) patients, the damage was located in the horizontal segment. There was no nerve damage intraoperatively. Preoperatively, House-Brackmann Grade III function was seen in 12 (60%) and Grade IV in 8 (40%), of patients operated within 4 weeks. After surgery, 20 (100%) patients had Grades I-II nerve function. Among the patients operated after 4 weeks, 4 (33.3%) had House-Brackmann Grade III, 6 (50%) had Grade IV and 2 (16.7%) had Grade V preoperatively. Postoperatively, 8 (66.7%) had Grades I-II, 2 (16.7%) had Grade III and 2 (16.7%) had Grade IV. These results indicated improvement in facial nerve function after surgery in patients operated within 4 weeks of symptom onset or thereafter (P = .000, P = .008, respectively; Table 2). A favourable prognosis was seen in 26 (81.3%) patients, and facial aralysis improved to an ordinary prognosis in 30 (93.8%) patients (Table 1). Facial nerve function recovered to Grade II in 100% (20 of 20 cases) of patients who underwent surgery within 4 weeks, and in 50.0% (6 of 12 cases) of patients who underwent surgery after 4 weeks, with a statistically significant difference between them (P = .001; Table 2). This suggests that the period of facial paralysis influenced the effects of decompression. Patients were divided into 2 groups based on the area of facial nerve decompression. Facial nerve function recovered to Grade II in 72.7% (16 of 22 cases) of patients who underwent nearly complete decompression and in 100% (10 of 10 cases) of patients who underwent partial decompression. There were no significant differences between them (P = .073; Table 2). Facial nerve function recovered to Grade II in 87.5% (14 cases) of patients in whom electroneurography showed lighter facial nerve functional damage and in 75% (12 cases) of patients in whom electroneurography showed worse damage, with no significant differences between them (P = .318; Table 2). We found that the duration of facial paralysis in cholesteatoma was a factor that influenced the recovery outcomes. All of the patients who underwent surgery within 4 weeks of palsy onset had good results, whereas patients operated after 4 weeks showed variable recovery. We also found that the results of partial decompression and near-complete decompression were good, with no difference between the 2 methods. In traumatic facial paralysis, near-complete decompression is preferred by most surgeons, from the geniculate ganglion to the stylomastoid foramen. Facial nerve decompression not only affects local lesions but also adjacent ones, thereby causing the entire canal to be affected.2 However, the area of surgical opening of the fallopian canal in cholesteatoma is still a subject of debate.3 Some recommend near-complete decompression to fully expose it,4 whereas others prefer a limited canal opening limited that encompasses as small an area as possible.1, 3 In this study, we found no significant difference between partial decompression and near-complete decompression. Yetiser et al4 reported that facial paralysis does not depend on the extent of destruction of the facial canal, and in some cases, massive exposure of the facial nerve has been found with minimal involvement of the nerve. As we observed intraoperatively, although the cholesteatoma affected a wide area, most of them only invaded a small part of the facial nerve. This may be the reason why partial decompression achieves a similar result to near-complete decompression. We acknowledge the possibility that the lesions in patients undergoing partial decompressions may have been lighter than in those undergoing near-complete decompression. The relatively limited sample of 32 patients indicated that it was prone to bias, particularly as a retrospective study. Further studies are needed to assess this. The time from onset of facial paralysis to surgery may be an important prognostic factor, because we found that patients who received surgery within 4 weeks had better outcomes than those who underwent surgery later. Previous studies have reported similar results, namely, that early surgical intervention can lead to better facial nerve function.5 Although the time points among these studies were not the same, all of the authors believed that compression resulting from oedema, and direct inflammation of the nerve by bacteria or neurotoxic substances, which may be secreted from the cholesteatoma matrix,6, 7 can cause damage to the facial nerve and prolonged infection of the facial nerve can lead to irreversible damage to these fibres. Recovery of facial function depends on the prompt removal of the infection. Thus, early surgical treatment is more likely to promote functional recovery of the facial nerve. The electroneurography test stimulates the foramen stylomastoideum; because of the lag in the extension of a facial nerve injury into the periphery, there is also a lag in the altered response to stimulation. In conclusion, early surgical treatment is more likely to result in a good prognosis in patients with facial paralysis secondary to cholesteatoma otitis media. Unlike other causes of facial paralysis, the integrity of the sheath membrane should be preserved to prevent the spread of inflammation. Facial nerve recovery was attained by most patients within a year after the operation. This study received support from the National Natural Science Foundation of China (grant No. 81371085; 81400466), Shanghai Pujiang Program (grant No. 15PJD030) and Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (grant No. 20152525 and No. 20152526). None to declare.